[1] Su CC, Chen BS, Chen HH, et al. Improved trends in the mortality-to-incidence ratios for liver cancer in countries with high development index and health expenditures. Healthcare (Basel), 2023, 11(2):159. [2] Zhou K, Gainey CS, Dodge JL, et al. Diverging incidence trends for hepatocellular carcinoma in rural and urban settings in the United States. Clin Gastroenterol Hepatol, 2022, 20(5):1180-1185. [3] An L, Zheng R, Zhang S, et al. Hepatocellular carcinoma and intrahepatic cholangiocarcinoma incidence between 2006 and 2015 in China: estimates based on data from 188 population-based cancer registries. Hepatobiliary Surg Nutr, 2023, 12(1):45-55. [4] Mei Q, Yu M, Chen Q. Clinical value of contrast-enhanced ultrasound in early diagnosis of small hepatocellular carcinoma (≤ 2 cm). World J Clin Cases, 2022, 10(24):8525-8534. [5] Gupta P, Soundararajan R, Patel A, et al. Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis. J Hepatol, 2021, 75(1):108-119. [6] Meng XP, Wang YC, Zhou JY, et al. Comparison of MRI and CT for the prediction of microvascular invasion in solitary hepatocellular carcinoma based on a non-radiomics and radiomics method: which imaging modality is better? J Magn Reson Imaging, 2021, 54(2):526-536. [7] Yu Y, Fan Y, Wang X, et al. Gd-eob-dtpa-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (vetc) and patient prognosis in hepatocellular carcinoma. Eur Radiol, 2022, 32(2):959-970. [8] Dundar I, Ozgokce M, Durmaz F, et al. Efficiency of diffusion-weighted MRI for differentiating radiologically similar simple and type I hydatid cysts of the liver. Acta Radiol, 2022, 63(2):143-148. [9] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版). 中华肝脏病杂志,2020,28(2):112-128. [10] Marrero JA, Ahn J, Rajender Reddy K, et al. ACG clinical guideline: the diagnosis and management of focal liver lesions. Am J Gastroenterol, 2014, 109(9):1328-1347. [11] Liu Z, Xu K, Jiang Y, et al. Global trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study. Int J Epidemiol, 2021, 50(1):128-142. [12] Li C, He WQ. The impact of universal hepatitis b vaccine on the trend of liver cancer from the global burden of disease study 2017. Liver Int, 2021, 41(8):1762-1774. [13] Dong Y, Chen S, Möller K, et al. Applications of dynamic contrast-enhanced ultrasound in differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in non-cirrhotic liver. Ultrasound Med Biol, 2023, 49(8):1780-1788. [14] 施莹, 柏根基, 孙阳. 多模态MRI对肝硬化增生性结节与小肝癌的鉴别诊断价值探讨. 实用肝脏病杂志, 2022, 25(5):722-725. [15] Mulé S, Galletto Pregliasco A, Tenenhaus A,et al. Multiphase liver MRI for identifying the macrotrabecular-massive subtype of hepatocellular carcinoma. Radiology, 2020, 295(3):562-571. [16] Khatri G, Pedrosa I, Ananthakrishnan L, et al. Abbreviated-protocol screening MRI vs. complete-protocol diagnostic MRI for detection of hepatocellular carcinoma in patients with cirrhosis: an equivalence study using li-rads v2018. J Magn Reson Imaging, 2020, 51(2):415-425. [17] Coman D, Peters DC, Walsh JJ,et al. Extracellular pH mapping of liver cancer on a clinical 3T MRI scanner. Magn Reson Med, 2020, 83(5):1553-1564. [18] Sivesgaard K, Larsen LP, Sørensen M,et al. Whole-body MRI added to gadoxetic acid-enhanced liver MRI for detection of extrahepatic disease in patients considered eligible for hepatic resection and/or local ablation of colorectal cancer liver metastases. Acta Radiol, 2020, 61(2):156-167. [19] Tanaka T, Saito K, Yunaiyama D,et al. Diffusion-weighted imaging might be useful for reactive lymphoid hyperplasia diagnosis of the liver: a case report. World J Clin Cases, 2020, 8(21):5313-5319. [20] Riexinger AJ, Martin J, Rauh S,et al. On the field strength dependence of bi- and triexponential intravoxel incoherent motion (ivim) parameters in the liver. J Magn Reson Imaging, 2019, 50(6):1883-1892. [21] Wan Q, Lei Q, Wang P,et al. Intravoxel incoherent motion diffusion-weighted imaging of lung cancer: comparison between turbo spin-echo and echo-planar imaging. J Comput Assist Tomogr, 2020, 44(3):334-340. |